What’s in a name? An awful lot when it comes to biosimilars. A newly released survey suggests variations in how biosimilars are named may affect the willingness of pharmacists to…
The post Biosimilar names may affect pharmacist dispensing habits appear…
Biosimilar names may affect pharmacist dispensing habits Read Post »
A new study suggests that a group of biosimilar drugs, which are used to treat such afflictions as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, appear as safe and effective…
The post Some biosimilars are just as good as some pricey …
Some biosimilars are just as good as some pricey biologics Read Post »
In the world of healthcare, few topics spark as much debate and confusion as prescription drug pricing. Have you ever […]
Have you ever wondered why some medications seem to cost an arm and a leg, while others are surprisingly affordable? […]
When Do Drug Patents Expire: Understanding the Lifecycle of Pharmaceutical Innovations Read Post »
Thank you for your interest in submitting a guest article! Submit your guest article here DrugPatentWatch is interested in sharing and promoting content that is drug approvals, patent expirations, and…
The post DrugPatentWatch Guest Article Agreement a…
I will be giving a pair of talks on biotechnology commercialization at the University of Texas at Arlington on November
Discussing Biotechnology Commercialization at UT Arlington Read Post »
This is a guest post from Rick Shalvoy, CEO, Consumer Health Education Programs The recent FDA approval of AbbVie’s Mavyret™ DAA (direct-acting
Just how big is the hepatitis C market in the United States? Read Post »
Transformation of a new scientific idea into a new oncology-based drug requires a tremendous amount of time, effort and investment. The
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
Patenting the Microbiome – Part 2: Microbiome IP Panel, 2017 BIO Convention Read Post »
Get Customized Access to DrugPatentWatch’s Rich Database DrugPatentWatch provides deep actionable business intelligence on small-molecule drugs and the 1.3 million
Integrate DrugPatentWatch Into Your Application or Data Store Read Post »
Get new actionable insights and updates from BiotechBlog
